Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study

Author(s):
Huizinga, T.W.J. (0000-0001-7033-7520); Conaghan, P.G.; Martin-Mola, E.; Schett, G.; Amital, H.; Xavier, R.M.; Troum, O.; Aassi, M.; Bernasconi, C.; Dougados, M.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2015), Vol. 74, no. 1, p. 35-43
hdl
1887/101651
doi
10.1136/annrheumdis-2014-205752